BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mooranian A, Negrulj R, Takechi R, Mamo J, Al-Sallami H, Al-Salami H. The biological effects of the hypolipidaemic drug probucol microcapsules fed daily for 4 weeks, to an insulin-resistant mouse model: potential hypoglycaemic and anti-inflammatory effects. Drug Deliv Transl Res 2018;8:543-51. [PMID: 29313296 DOI: 10.1007/s13346-017-0473-5] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
Number Citing Articles
1 Mooranian A, Zamani N, Ionescu CM, Takechi R, Luna G, Mikov M, Goločorbin-Kon S, Kovačević B, Al-Salami H. Oral gavage of nano-encapsulated conjugated acrylic acid-bile acid formulation in type 1 diabetes altered pharmacological profile of bile acids, and improved glycaemia and suppressed inflammation. Pharmacol Rep 2020;72:368-78. [PMID: 32048259 DOI: 10.1007/s43440-019-00030-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Mooranian A, Raj Wagle S, Kovacevic B, Takechi R, Mamo J, Lam V, Watts GF, Mikov M, Golocorbin-Kon S, Stojanovic G, Al-Sallami H, Al-Salami H. Bile acid bio-nanoencapsulation improved drug targeted-delivery and pharmacological effects via cellular flux: 6-months diabetes preclinical study. Sci Rep 2020;10:106. [PMID: 31919411 DOI: 10.1038/s41598-019-53999-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
3 Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H. Eudragit®-based microcapsules of probucol with a gut-bacterial processed secondary bile acid. Ther Deliv 2018;9:811-21. [PMID: 30444461 DOI: 10.4155/tde-2018-0036] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
4 Foster T, Ionescu C, Walker D, Jones M, Wagle S, Kovacevic B, Brown D, Mikov M, Mooranian A, Al-Salami H. Chemotherapy-induced hearing loss: the applications of bio-nanotechnologies and bile acid-based delivery matrices. Ther Deliv 2021;12:723-37. [PMID: 34697955 DOI: 10.4155/tde-2021-0050] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Wagle SR, Kovacevic B, Walker D, Ionescu CM, Jones M, Stojanovic G, Kojic S, Mooranian A, Al-Salami H. Pharmacological and Advanced Cell Respiration Effects, Enhanced by Toxic Human-Bile Nano-Pharmaceuticals of Probucol Cell-Targeting Formulations. Pharmaceutics 2020;12:E708. [PMID: 32751051 DOI: 10.3390/pharmaceutics12080708] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
6 Elnashar M, Vaccarezza M, Al-Salami H. Cutting-edge biotechnological advancement in islet delivery using pancreatic and cellular approaches. Future Sci OA 2020;7:FSO660. [PMID: 33552541 DOI: 10.2144/fsoa-2020-0105] [Reference Citation Analysis]
7 Mooranian A, Foster T, Ionescu CM, Walker D, Jones M, Wagle SR, Kovacevic B, Chester J, Johnston E, Wong E, Atlas MD, Mikov M, Al-Salami H. Enhanced Bilosomal Properties Resulted in Optimum Pharmacological Effects by Increased Acidification Pathways. Pharmaceutics 2021;13:1184. [PMID: 34452145 DOI: 10.3390/pharmaceutics13081184] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Al-Salami H. Stability and biological testing of taurine-conjugated bile acid antioxidant microcapsules for diabetes treatment. Ther Deliv 2019;10:99-106. [PMID: 30729887 DOI: 10.4155/tde-2018-0034] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
9 Mooranian A, Zamani N, Takechi R, Al-Sallami H, Mikov M, Goločorbin-Kon S, Kovacevic B, Arfuso F, Al-Salami H. Pharmacological effects of nanoencapsulation of human-based dosing of probucol on ratio of secondary to primary bile acids in gut, during induction and progression of type 1 diabetes. Artif Cells Nanomed Biotechnol 2018;46:S748-54. [PMID: 30422681 DOI: 10.1080/21691401.2018.1511572] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mooranian A, Zamani N, Takechi R, Luna G, Mikov M, Goločorbin-Kon S, Elnashar M, Arfuso F, Al-Salami H. An in vivo pharmacological study: Variation in tissue-accumulation for the drug probucol as the result of targeted microtechnology and matrix-acrylic acid optimization and stabilization techniques. PLoS One 2019;14:e0214984. [PMID: 30947243 DOI: 10.1371/journal.pone.0214984] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
11 Wagle SR, Kovacevic B, Walker D, Ionescu CM, Shah U, Stojanovic G, Kojic S, Mooranian A, Al-Salami H. Alginate-based drug oral targeting using bio-micro/nano encapsulation technologies. Expert Opin Drug Deliv 2020;17:1361-76. [PMID: 32597249 DOI: 10.1080/17425247.2020.1789587] [Cited by in Crossref: 7] [Cited by in F6Publishing: 10] [Article Influence: 3.5] [Reference Citation Analysis]
12 Nemati M, Fathi-Azarbayjani A, Al-Salami H, Roshani Asl E, Rasmi Y. Bile acid-based advanced drug delivery systems, bilosomes and micelles as novel carriers for therapeutics. Cell Biochem Funct 2022. [PMID: 35830577 DOI: 10.1002/cbf.3732] [Reference Citation Analysis]
13 Mathavan S, Ionescu CM, Kovacevic B, Mikov M, Golocorbin-Kon S, Mooranian A, Dass CR, Al-Salami H. Histological effects of pharmacologically active human bile acid nano/micro-particles in Type-1 diabetes. Ther Deliv 2020;11:157-71. [PMID: 32046598 DOI: 10.4155/tde-2019-0079] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
14 Mooranian A, Zamani N, Takechi R, Luna G, Mikov M, Goločorbin-Kon S, Kovacevic B, Arfuso F, Al-Salami H. Modulatory Nano/Micro Effects of Diabetes Development on Pharmacology of Primary and Secondary Bile Acids Concentrations. Curr Diabetes Rev 2020;16:900-9. [PMID: 32013849 DOI: 10.2174/1389450121666200204115121] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
15 Mooranian A, Jones M, Walker D, Ionescu CM, Wagle SR, Kovacevic B, Chester J, Foster T, Johnston E, Kuthubutheen J, Brown D, Atlas MD, Mikov M, Al-Salami H. Pharmacological Dose-Effect Profiles of Various Concentrations of Humanised Primary Bile Acid in Encapsulated Cells. Nanomaterials (Basel) 2022;12:647. [PMID: 35214975 DOI: 10.3390/nano12040647] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Mooranian A, Foster T, Ionescu CM, Carey L, Walker D, Jones M, Wagle SR, Kovacevic B, Chester J, Johnstone E, Kuthubutheen J, Brown D, Atlas MD, Mikov M, Al-Salami H. The Effects of Primary Unconjugated Bile Acids on Nanoencapsulated Pharmaceutical Formulation of Hydrophilic Drugs: Pharmacological Implications. Drug Des Devel Ther 2021;15:4423-34. [PMID: 34720580 DOI: 10.2147/DDDT.S328526] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Kovacevic B, Al-Salami H. Bio Micro-Nano Technologies of Antioxidants Optimised Their Pharmacological and Cellular Effects, ex vivo, in Pancreatic β-Cells. Nanotechnol Sci Appl 2020;13:1-9. [PMID: 32021126 DOI: 10.2147/NSA.S212323] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Mooranian A, Ionescu CM, Wagle SR, Kovacevic B, Walker D, Jones M, Chester J, Foster T, Johnston E, Kojic S, Stojanovic G, Mikov M, Al-salami H. Taurine Grafted Micro-Implants Improved Functions without Direct Dependency between Interleukin-6 and the Bile Acid Lithocholic Acid in Plasma. Biomedicines 2022;10:111. [DOI: 10.3390/biomedicines10010111] [Reference Citation Analysis]
19 Caspi M, Wittenstein A, Kazelnik M, Shor-Nareznoy Y, Rosin-Arbesfeld R. Therapeutic targeting of the oncogenic Wnt signaling pathway for treating colorectal cancer and other colonic disorders. Adv Drug Deliv Rev 2021;169:118-36. [PMID: 33346022 DOI: 10.1016/j.addr.2020.12.010] [Cited by in Crossref: 26] [Cited by in F6Publishing: 17] [Article Influence: 26.0] [Reference Citation Analysis]
20 Mooranian A, Jones M, Ionescu CM, Walker D, Wagle SR, Kovacevic B, Chester J, Foster T, Johnston E, Mikov M, Al-Salami H. Pharmaceutical formulation and polymer chemistry for cell encapsulation applied to the creation of a lab-on-a-chip bio-microsystem. Ther Deliv 2021. [PMID: 34821516 DOI: 10.4155/tde-2021-0067] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Yan X, Chang Y, Qian X. Preparation and Self-Repairing Properties of Urea Formaldehyde-Coated Epoxy Resin Microcapsules. International Journal of Polymer Science 2019;2019:1-11. [DOI: 10.1155/2019/7215783] [Cited by in Crossref: 9] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
22 Mooranian A, Zamani N, Mikov M, Goločorbin-kon S, Stojanovic G, Arfuso F, Al-salami H. Novel nano-encapsulation of probucol in microgels: scanning electron micrograph characterizations, buoyancy profiling, and antioxidant assay analyses. Artificial Cells, Nanomedicine, and Biotechnology 2018;46:S741-7. [DOI: 10.1080/21691401.2018.1511571] [Cited by in Crossref: 10] [Cited by in F6Publishing: 13] [Article Influence: 2.5] [Reference Citation Analysis]
23 Mamo JC, Lam V, Al-Salami H, Brook E, Mooranian A, Nesbit M, Graneri L, D'Alonzo Z, Fimognari N, Stephenson A, Takechi R. Sodium alginate capsulation increased brain delivery of probucol and suppressed neuroinflammation and neurodegeneration. Ther Deliv 2018;9:703-9. [PMID: 30277134 DOI: 10.4155/tde-2018-0033] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
24 Mooranian A, Chester J, Johnston E, Ionescu CM, Walker D, Jones M, Wagle SR, Kovacevic B, Foster T, Mikov M, Al-salami H. Reduced Cytokine Tumour Necrosis Factor by Pharmacological Intervention in a Preclinical Study. Biomolecules 2022;12:877. [DOI: 10.3390/biom12070877] [Reference Citation Analysis]
25 da Silva EB, Eichwald T, Glaser V, Varela KG, Baptistella AR, de Carvalho D, Remor AP. Protective Effects of Probucol on Different Brain Cells Exposed to Manganese. Neurotox Res 2022. [PMID: 35043377 DOI: 10.1007/s12640-021-00458-3] [Reference Citation Analysis]
26 Mooranian A, Zamani N, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Kovacevic B, Al-Salami H. A second-generation micro/nano capsules of an endogenous primary un-metabolised bile acid, stabilized by Eudragit-alginate complex with antioxidant compounds. Saudi Pharm J 2020;28:165-71. [PMID: 32042255 DOI: 10.1016/j.jsps.2019.11.017] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
27 Mooranian A, Carey L, Ionescu CM, Walker D, Jones M, Wagle SR, Kovacevic B, Foster T, Chester J, Johnston E, Mikov M, Al-Salami H. The Effects of Accelerated Temperature-Controlled Stability Systems on the Release Profile of Primary Bile Acid-Based Delivery Microcapsules. Pharmaceutics 2021;13:1667. [PMID: 34683960 DOI: 10.3390/pharmaceutics13101667] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Wagle SR, Kovacevic B, Ionescu CM, Walker D, Jones M, Carey L, Takechi R, Mikov M, Mooranian A, Al-Salami H. Pharmacological and Biological Study of Microencapsulated Probucol-Secondary Bile Acid in a Diseased Mouse Model. Pharmaceutics 2021;13:1223. [PMID: 34452184 DOI: 10.3390/pharmaceutics13081223] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Chester J, Johnston E, Walker D, Jones M, Ionescu CM, Wagle SR, Kovacevic B, Brown D, Mikov M, Mooranian A, Al-Salami H. A Review on Recent Advancement on Age-Related Hearing Loss: The Applications of Nanotechnology, Drug Pharmacology, and Biotechnology. Pharmaceutics 2021;13:1041. [PMID: 34371732 DOI: 10.3390/pharmaceutics13071041] [Reference Citation Analysis]
30 Mooranian A, Ionescu CM, Wagle SR, Kovacevic B, Walker D, Jones M, Chester J, Johnston E, Danic M, Mikov M, Dass C, Al-Salami H. Chenodeoxycholic Acid Pharmacology in Biotechnology and Transplantable Pharmaceutical Applications for Tissue Delivery: An Acute Preclinical Study. Cells 2021;10:2437. [PMID: 34572086 DOI: 10.3390/cells10092437] [Reference Citation Analysis]
31 Mooranian A, Zamani N, Takechi R, Al-Sallami H, Mikov M, Goločorbin-Kon S, Kovacevic B, Arfuso F, Al-Salami H. Probucol-poly(meth)acrylate-bile acid nanoparticles increase IL-10, and primary bile acids in prediabetic mice. Ther Deliv 2019. [PMID: 31646943 DOI: 10.4155/tde-2019-0052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
32 Mooranian A, Zamani N, Luna G, Al-Sallami H, Mikov M, Goločorbin-Kon S, Stojanovic G, Arfuso F, Kovacevic B, Al-Salami H. Bile acid-polymer-probucol microparticles: protective effect on pancreatic β-cells and decrease in type 1 diabetes development in a murine model. Pharm Dev Technol 2019;24:1272-7. [PMID: 31557068 DOI: 10.1080/10837450.2019.1665069] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]